SOURCE: Medizone International, Inc.

Medizone International, Inc.

May 31, 2011 08:35 ET

Medizone International to Host Conference Call

SAN FRANCISCO, CA--(Marketwire - May 31, 2011) - Medizone International, Inc. (OTCQB: MZEI) (OTCBB: MZEI) will hold a teleconference on Wednesday, June 8, 2011 at 3:00 p.m., PDT, to discuss company developments. Investors can listen to the call by dialing the following numbers at least five minutes prior to the conference.

Primary North American number (916) 209-4534 Backup (619) 276-6333

EU and UK (Germany): +49 157-02488180

ENTER PIN # 966314 AFTER PHONE NUMBER

For those who cannot listen to the live broadcast, a replay will be available after the call on the company's website at www.medizoneint.com.

Regarding its plans, Edwin G. Marshall, Chairman of Medizone, noted, "We have received numerous inquiries from investors and stockholders concerning our progress and plans for marketing our AsepticSure™ technology. A conference call is a great way to appropriately respond to these inquiries."

Company executives will make opening statements. This will then be followed by a question and answer session. All questions and inquiries must be submitted by email tooperations@medizoneint.com no later than Monday, June 6, 2011.

Medizone International, Inc. is a research and development company engaged in developing its AsepticSure™ System to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure. A government variant is being developed for bio-terrorism counter measures.

Safe Harbor

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including global economic conditions generally, reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.

Contact Information

  • Investor Relations:
    The Eversull Group, Inc.
    Jack Eversull
    972-571-1624
    214-469-2361 (fax)
    Email Contact